Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P170034/S017

Hydrus Microstent

Alcon Research, LLC · Decision date Apr 23, 2026

FDA DECISIONP170034/S017

What did the FDA decide?

FDA records P170034/S017 as a supplement to PMA P170034, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Apr 23, 2026.

FDA approval order statement

an addition of alternate suppliers for non-patient contacting components of the device delivery system
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ophthalmic
Decision date
Apr 23, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P170034/S017
Regulatory pathway
PMA supplement
Product code
OGO
Decision code
OK30
Decision date
Apr 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Intraocular pressure lowering implant.

Product code
OGO
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P170034/S017 received

    Application receipt date recorded by FDA.

  2. P170034/S017 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P170034. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P170034

Product / regulatory recordCompanyPathwayDecision dateSource
Hydrus MicrostentP170034/S018
Alcon Research, LLCPMA supplementJun 4, 2026FDA

Explore the linked device profile

Other records with product code OGO

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Alcon Research, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6201 S. Fwy., Fort Worth, TX, 76134

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records